Updated guideline for the management of upper respiratory tract infections in South Africa: 2008

References

• Jacobs MR. World trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J 2003; 22: S109–S119
   PubMed Web of Science ®Google Scholar
• Del Mar C. Managing sore throat: a literature review. Med J Aust 1992; 156: 572–575
   PubMed Web of Science ®Google Scholar
• Del Mar CB, Glasziou PP, Spinks AB. Antibiotics for sore throat (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, 2003
   Google Scholar
• Pechere JC. Parameters important in short antibiotic courses. J Int Med Res 2000; 28(Suppl 1): 3A–12A
   PubMed Web of Science ®Google Scholar
• Huebner RE, Wasas AD, Hockman M, et al. Bacterial aetiology of non-resolving otitis media in South African children. J Laryngol Otol 2003; 117: 169–172
   PubMed Web of Science ®Google Scholar
• Graham A, Fahey T. Sore throat: diagnostic and therapeutic dilemmas. BMJ 1999; 319: 173–174
   PubMed Web of Science ®Google Scholar
• Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. J Pediatr 1992; 121: 569–572
   PubMed Web of Science ®Google Scholar
• Bass JW. A review of the rationale and advantages of various mixtures of benzathine penicillin G. Pediatrics 1996; 97: 960–963
   PubMed Web of Science ®Google Scholar
• Dicuonzo G, Fiscarelli E, Gherardi G, et al. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 2002; 46: 3987–3990
   PubMed Web of Science ®Google Scholar
• Reinert RR, Lutticken R, Bryskier A, Al-Lahham A. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000–2001. Antimicrob Agents Chemother 2003; 47: 489–493
   PubMed Web of Science ®Google Scholar
• Clegg HW, Ryan AG, Dallas SD, et al. Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin. Pediatric Inf Dis J 2006; 25: 761–767
   PubMed Web of Science ®Google Scholar
• Lennon DR, Farrell E, Martin DR, Stewart JM. Once-daily amoxicillin versus twice-daily penicillin V in group A β-haemolytic streptococcal pharyngitis. Arch Dis Child 2008; 93: 474–478
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Group A streptococcal infections. In: Pickering LK, ed. Red Book: 2003 Report of the Committee of Infectious Diseases. Elk Grove Village, Ill.: American Academy of Pediatrics, 2003: 578–580
   Google Scholar
• Adam D, Scholz H, Helmerking M. Short course antibiotic treatment of 4782 culture-proven cases of group A streptococcal tonsillo-pharyngitis and incidence of poststreptococcal sequelae. J Infect Dis 2000; 182: 509–516
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991; 10: 275–281
   PubMed Web of Science ®Google Scholar
• Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections. Drugs Exp Clin Res 1987; 13: 91–94
   PubMedGoogle Scholar
• Portier H, Chavanet P, Gouyon JB, et al. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother 1990; 26: 79–85
   PubMed Web of Science ®Google Scholar
• Mehra S, Van Moerkerke M, Welck J, et al. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Dis J 1998; 17: 452–457
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Cohen R. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis. Pediatr Infect Dis J 1997; 16: 680–695
   PubMed Web of Science ®Google Scholar
• Hoppe HL, Johnson CE. Otitis media: focus on antimicrobial resistance and new treatment options. Am J Heath Syst Pharm 1998; 55(18): 1881–1897
   PubMed Web of Science ®Google Scholar
• Marchant CD, Carlin SA, Johnson CE, et al. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the “Pollyanna phenomenon”. J Pediatr 1992; 120: 72–77
   PubMed Web of Science ®Google Scholar
• Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A meta-analysis. BMJ 1997; 314: 1526–1529
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Diagnostic accuracy of otitis media and tympanocentesis skills assessment among paediatricians. Eur J Clin Microbiol Infect Dis 2003; 22: 519–524
   PubMed Web of Science ®Google Scholar
• Bradley JS, Nelson JD. Nelson's Pocketbook of Pediatric Antimicrobial Therapy. Lippincott Williams and Wilkins, 2002. www.skyscape.com (accessed March 2004)
   Google Scholar
• Turner D, Leibovitz E, Aran A, et al. Acute otitis media in infants younger than two months of age: microbiology, clinical presentation and therapeutic approach. Pediatr Infect Dis J 2002; 21: 669–674
   PubMed Web of Science ®Google Scholar
• Dohar J, Giles W, Roland P, Bikhazi N, Carroll S, Moe R, et al. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. Pediatrics 2006; 118: e561-e569
   PubMed Web of Science ®Google Scholar
• Dagan R, Hoberman A, Johnson C, et al. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J 2001; 20: 829–837
   PubMed Web of Science ®Google Scholar
• Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 15: 255–259
   PubMed Web of Science ®Google Scholar
• Nicolau DP, Sutherland CA, Arguedas A, Dagan R, Pichichero ME. Pharmacokinetics of cefprozil in plasma and middle ear fluid in children undergoing treatment for acute otitis media. Pediatr Drugs 2007; 9: 119–123
   PubMedGoogle Scholar
• Pichichero ME, Dagan R, Arguedas A, et al. A multi-center, open- labeled study of cefprozil in children with persistent and recurrent acute otitis media. Abstract G-819. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D. C., December, 2005
   Google Scholar
• Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. Pediatr Infect Dis J 1998; 17: 1126–1131
   PubMed Web of Science ®Google Scholar
• Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother 2000; 44: 43–50
   PubMed Web of Science ®Google Scholar
• Leiberman A, Leibovitz E, Piglansky L, et al. Bacteriologic and clinical efficacy of trimethoprim-sulfamethoxazole for treatment of acute otitis media. Pediatr Infect Dis J 2001; 20: 260–264
   PubMed Web of Science ®Google Scholar
• Ingvarsson L, Lundgren K. Penicillin treatment of acute otitis media in children. A study of the duration of treatment. Acta Otolaryngol 1982; 94: 283–287
   PubMed Web of Science ®Google Scholar
• Leibovitz E, Dagan R. Otitis media therapy and drug resistance. Infect Med 2001; 18: 263–270
   Web of Science ®Google Scholar
• Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 2006; 118: 865–873
   PubMed Web of Science ®Google Scholar
• Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization privately insured young children in the United States, 1997–2004. Pediatrics 2008; 121: 253–260
   PubMed Web of Science ®Google Scholar
• Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 2007; 119: 707–715
   PubMed Web of Science ®Google Scholar
• Casey JR. Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995–2003.
   Google Scholar
• Pediatr Infect Dis J 2004; 23: 824–828
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR, Hoberman A, Schwartz R. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003–2006.
   Google Scholar
• Clin Pediatr June 2008 (ePub ahead of print)
   Google Scholar
• Dunbar LM. Current issues in the management of bacterial respiratory tract disease: the challenge of antibacterial resistance. Am J Med Sci 2003; 326: 360–368
   PubMed Web of Science ®Google Scholar
• Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008; 371: 908–914
   PubMed Web of Science ®Google Scholar
• Ioannidis JPA, Chew P, Lau J. Standardized retrieval of side effects data for meta-analysis of safety outcomes. A feasibility study in acute sinusitis. J Clin Epidemiol 2002; 55: 619–626
   PubMed Web of Science ®Google Scholar
• Gwaltney JM Jr, Scheld WM, Sande MA, et al. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol 1992; 90: 457–461
   PubMed Web of Science ®Google Scholar
• Siegert R, Gehanno P, Nikolaidis P, et al. A comparison of the safety and efficacy of moxifloxacin (BAY 12–8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. Respir Med 2000; 94: 337–344
   PubMed Web of Science ®Google Scholar
• Roos K, Brunswig-Pitschner C, Kostrica R, et al. Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis. Chemotherapy 2002; 48: 100–108
   PubMed Web of Science ®Google Scholar
• Ariza H, Rojas R, Johnson P, et al. Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis. BMC Ear, Nose and Throat Disorders 2006: 6: 8–15
   Google Scholar
• Anon JB, Paglia M, Xiang J, Ambrose PG, Jones RN, Kahn JB. Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis. Diagn Microbiol Inf Dis 2007; 57: 105–107
   PubMed Web of Science ®Google Scholar
• Poole M, Anon J, Paglia M, Xiang J, Khashab M, Kahn J. A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. Otolaryngology- Head and Neck Surgery 2006; 134: 10–17
   PubMed Web of Science ®Google Scholar
• Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345: 804–809
   PubMed Web of Science ®Google Scholar